GREY:ICOTF - Post by User
Post by
Hampoooon Jun 14, 2018 9:22am
40 Views
Post# 28170893
Partnership Immune Pharmaceuticals (NASDAQ: IMNP)
Partnership Immune Pharmaceuticals (NASDAQ: IMNP)iCo Therapeutics identifies existing development stage assets for use in underserved ocular and infectious diseases. Such assets may exhibit utility in non-ophthalmic conditions outside the Companys core focus areas and if so the Company will seek to capture further value via partnerships, such as its partnership with, Immune Pharmaceuticals (NASDAQ: IMNP) which is in several Phase 2 studies involving iCo-008. iCo shares trade on the TSX Venture Exchange under the symbol ICO and on the OTCQB under the symbol ICOTF.